Kidney Cancer
465
61
85
262
Key Insights
Highlights
Success Rate
84% trial completion
Published Results
92 trials with published results (20%)
Research Maturity
262 completed trials (56% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
10.5%
49 terminated out of 465 trials
84.2%
-2.3% vs benchmark
8%
39 trials in Phase 3/4
35%
92 of 262 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 262 completed trials
Clinical Trials (465)
A Study of a Side Effects and Resource Navigation Program for People With Cancer
Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders
A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001)
Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer
Assessing Financial Toxicity Using the PROFFIT Questionnaire in Patients Treated With Mini-invasive Approach for Urological Malignancies.
Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START Trial
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
Project HERO: Health Empowerment & Recovery Outcomes
Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health
Lenalidomide in Treating Patients With Advanced or Unresectable Kidney Cancer
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer
Distance-Based Exercise to Preserve Function and Prevent Disability
Integrated Cancer Repository for Cancer Research
Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform (ELEPHAS-02)
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
Perioperative Ursodeoxycholic Acid for Renal Protection in Adults Undergoing Partial Nephrectomy for Renal Tumors
UroCCR Database: French Research Network for Kidney Cancer -UroCCR
The HistoSonics Edison™ System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY)
A Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)